Titre :
  • Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
Auteur : Bosly, André ; Sonet, Anne ; Pinkerton, C Ross ; McCowage, Geoffrey ; Bron, Dominique ; Sanz, Miguel A ; Van den Berg, Hendrik
Informations sur la publication : Cancer, 98, 5, (page 1048-1054)
Statut de publication : Publié, 2003-09
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Acute leukemia
Compassionate use
Hemodialysis
Hyperuricemia
Non-Hodgkin lymphoma
Rasburicase (Fasturtec®/Elitek®)
Tumor lysis syndrome
Mots-clés MeSH : Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Humans
Hyperuricemia -- drug therapy
Hyperuricemia -- etiology
Infant
Infusions, Intravenous
Lymphoma, Non-Hodgkin -- complications
Lymphoma, Non-Hodgkin -- drug therapy
Male
Middle Aged
Recombinant Proteins
Treatment Outcome
Tumor Lysis Syndrome -- drug therapy
Tumor Lysis Syndrome -- etiology
Urate Oxidase -- pharmacology
Urate Oxidase -- therapeutic use
Note : Clinical Trial
Journal Article
FLWIN
Langue :
  • Anglais
Identificateurs : urn:issn:0008-543X 
info:doi/10.1002/cncr.11612
info:pmid/12942574